Many growth stage companies that delayed fundraising in 2022 as valuations dipped will likely have to seek additional capital by the end of 2023, ...

Across the Adams Street platform, 2020 was a record year in terms of total deal count and volume for investments in behavioral health.

Adams Street led the Series E investment in Dremio, the SQL data lakehouse platform that enables enterprises to run mission-critical BI.

Adams Street is examining the blockchain and digital assets sector closely, while cautiously determining the best places to invest.

The market for Non-Fungible Tokens (NFTs) is expanding exponentially. The potential for this nascent sector extends far beyond digital art.

As a burgeoning construct, certain industry participants believe that decentralized autonomous organizations, or DAOs, may be the biggest innovati ...

Cloud-based DataOps software architectures collate and analyze large quantities of data held across multiple formats and locations, allowing compa ...

Tim Barry, CEO and Chair of VillageMD, talks with Adams Street’s Robin Murray about how value-based health care can provide patient outcomes for p ...

In the keynote session at the 2022 Adams Street European Conference in London, author Sebastian Mallaby discussed his book “The Power Law” and the ...

Adams Street invested in the $150mm Series B of Remote, a HR solution for companies to help employ full-time and contract workers globally.

Jeff Diehl, Adams Street’s Managing Partner & Head of Investments, shares observations and important considerations for private markets inves ...

Venture capital firms have a multi-decade history of facilitating innovation. Recent valuation corrections add to the venture opportunity, which w ...

Private Equity International recently spoke with Robin Murray, Tom Bremner, and Fred Wang to discuss the outlook on growth capital investing.

Adams Street invested in the $112 million Series D of Altruist, a vertically integrated, digital investment and custodial platform for independent ...

Innovative growth-stage companies in the $4.3 trillion US healthcare market are introducing potentially transformative approaches that cater to th ...